Lixisenatide: a new member of the glucagon-like peptide 1 receptor agonist class of incretin therapies
Regulatory changes : The FDA has been tightening rules around compounding, especially for GLP-1 medications, so availability can shift quickly
Semaglutide and Pharmacologic Rescue Semaglutide is a GLP-1 receptor agonist used primarily for weight management and type 2 diabetes control
Sassoon DJ, Tune JD, Mather KJ, Noblet JN, Eagleson MA, Conteh AM, Sturek JT, Goodwill AG
Krishnan A, Venkataraman J (2011) Prevalence of nonalcoholic fatty liver disease and its biochemical predictors in patients with type-2 diabetic mellitus
1 Its primary functions constitute the regulation of glucose homeostasis and weight management, in addition to its integral neuroprotective role